211At-OKT10-B10

N/A

Report date: 2026/03/14 20:00:17

Base Information

Drug Name211At-OKT10-B10
Drug Alias Name211At-Labeled Anti-CD38 Monoclonal AntibodyAstatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10[211At]OKT10-B10Astatine 211-labeled Anti-CD38 Monoclonal Antibody OKT10-B10Astatine At 211 Anti-CD38 MoAb OKT10-B10 +[7] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyRadiation-emitting products > Radioactive therapeutic agentBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnostics +[5] 
Mechanisms of ActionAnti-CD38
TargetsLymphocyte differentiation antigen CD38
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesFred Hutchinson Cancer Research Center
China Registration ClassN/A

Develop Information

Active CompaniesFred Hutchinson Cancer Research Center
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A